• Home >
  • Vital Signs The Analyst's Perspective - September 2015 Issue

Vital Signs The Analyst's Perspective - September 2015 Issue

30-Sep-2015  /  Research Code: 9A35-00-40-00-00  /  SKU: HC02617-AP-MR_16739  /  
Region: Asia Pacific

USD 450

* Required Fields

USD 450

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.

Table of Contents

Vital Signs The Analyst's Perspective - September 2015 IssueVital Signs - September 2015 IssueSeptember Issue




Related Research

Australian Retail Technology Report, 2016–2021

Release Date : 11-Oct-17

Region : Asia Pacific

Growth Opportunities in Asia-Pacific Hospital Healthcare Information Technology, 2016–2021

Release Date : 08-Aug-17

Region : Asia Pacific

China Medical Imaging Equipment Market, Forecast to 2021

Release Date : 13-Jul-17

Region : Asia Pacific

Growth Opportunities in APAC Oncology Diagnostics Market, Forecast to 2021

Release Date : 06-Jul-17

Region : Asia Pacific

Malaysia, Singapore, and Indonesia Transformational Health Insights, 2017–2022

Release Date : 22-Jun-17

Region : Asia Pacific

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.